Inhibrx Inc. (INBX) Prices 7M Share IPO at $17/Sh

Inhibrx, Inc. (NASDAQ: INBX) today announced the pricing of its initial public offering of 7,000,000 shares of common stock at a price to the public of $17.00 per share. All of the shares of common stock are being offered by Inhibrx. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Inhibrx, are expected to be $119.0 million. Inhibrx's common stock is expected to begin trading on the Nasdaq Global Market on August 19, 2020, under the symbol "INBX". The offering is expected to close on August 21, 2020, subject to the satisfaction of customary closing conditions. In addition, Inhibrx has granted the underwriters a 30-day option to purchase up to 1,050,000 additional shares of common stock at the initial public offering price, less underwriting discounts and commissions.

Jefferies, Evercore ISI and Credit Suisse are acting as joint book-running managers for the offering. LifeSci Capital is acting as co-manager for the offering.

You May Also Be Interested In

• CoVolt Power files for proposed IPO
• Denarius Metals acquires 15% stake in Copper Giant, Trafigura invests
• MAIA Biotechnology (MAIA) files $150M mixed shelf